International Clinical Trial: Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07310407) titled 'Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)' on Dec. 16, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Ain Shams University

Condition: NAFLD

Intervention: Drug: Rutin + Vitamin C Drug: Vitamin C 500mg

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: January 1, 2026

Target Sample Size: 120

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT073104...